Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GlaxoSmithKline claims novel compounds for the treatment of anemia

April 27, 2009

Kowa claims novel G-protein-coupled receptor 40 and 120 agonists as antidiabetic agents

April 27, 2009

Takeda discontinues TAK-379 development for diabetes

April 24, 2009

Dr. Reddy's launches Redispar in India for SHPT due to chronic kidney disease

April 24, 2009

Novel gonadotropin-releasing hormone receptor antagonists claimed by Kissei

April 24, 2009

Chugai receives approval in Japan for changes to API manufacturing of Epogin

April 23, 2009

BioMarin initiates phase I/II trial for BMN-110 in Morquio A syndrome

April 23, 2009

Shionogi discloses novel compounds for the treatment of diabetes

April 23, 2009

Sanofi-aventis launches Apidra SoloSTAR insulin delivery device in the U.S.

April 21, 2009

Merck Serono launches Kuvan in Europe

April 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...